S

SmarterDx

Analyzes medical data to support diagnoses

Overview

SmarterDx analyzes medical data from patient charts to support faster, data-driven clinical decisions. It uses counterfactual modeling to identify missed Clinical Documentation Improvement (CDI) and coding opportunities, helping providers improve patient care and increase revenue. The platform processes diverse data points such as notes, lab results, medications, orders, vitals, and ICD-10 codes, turning slow, manual searches into rapid, informed decisions. Unlike traditional approaches, SmarterDx emphasizes surfacing missed opportunities in documentation and coding, and offers a risk-free business model with a guaranteed 5:1 return on investment, aiming to streamline workflows, enhance patient care, and boost revenue for healthcare providers.

Work here?Claim your company

About SmarterDx

Simplify's Rating
Why SmarterDx is rated
B+
Rated B on Competitive Edge
Rated A on Growth Potential
Rated B on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningHealthcare

Company Size

201-500

Company Stage

Series B

Total Funding

$56M

Headquarters

New York City, New York

Founded

2020

Get referred to SmarterDx

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • New Mountain Capital invested in April 2025, funding product expansion.
  • SmarterDx served 85 health systems and 300 hospital sites by October 2026.
  • Updated 2026 evidence cites roughly $150 million annual revenue and rapid scale.

What critics are saying

  • Hospitals can replace SmarterDx with in-house CDI teams after EMR upgrades.
  • CodaMetrix, AKASA, and MDaudit compress pricing on adjacent revenue-integrity workflows.
  • If payer denials normalize, SmarterDx's ROI story weakens and churn rises.

What makes SmarterDx unique

  • Physician-founded platform reviews 100% of discharges, not sampled charts.
  • SmarterPrebill and SmarterDenials span pre-bill capture and post-denial appeals.
  • McLaren Health reported $11 million annualized net new revenue after adoption.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$56M

Above

Industry Average

Funded Over

2 Rounds

Notable Investors:
Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
$50M
$65M
$100M

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • Free One Medical membership
  • Parental Leave
  • Remote Work Options

Growth & Insights and Company News

6 month growth

3%

1 year growth

3%

2 year growth

6%
The New York Times
Sep 24th, 2026
Battle of hospital A.I. vs. Insurer A.I. Is pushing medical costs higher.

Battle of hospital A.I. vs. Insurer A.I. Is pushing medical costs higher. The use of artificial intelligence by hospitals and health insurers is escalating their longstanding feud over paying for medical care. Listen · 8:33 min Sept. 24, 2026Updated 7:03 a.m. ET In the latest sign that artificial intelligence is fueling higher health care costs, a group of insurers released a report Thursday claiming that hospitals' use of A.I. was responsible for nearly $1 billion in additional expenses over two years. Using codes for various medical conditions, hospitals submitted claims for tens of thousands of patients that described their illnesses as more complex in 2024 and 2025 than in 2023. Despite the added conditions, there was no evidence that the patients had received different treatment from the hospitals, according to the analysis by the Blue Cross Blue Shield Association, which represents state Blue Cross plans. Using A.I. tools, hospitals are collecting more information about their patients, and submitting bigger claims, the association said. "Coding is changing because of this technology," said Luke Chalker, a senior vice president at the association. By describing patients as having more complicated conditions and adding a secondary diagnosis, like anemia or low sodium, the hospitals were paid an average of nearly $12,000 more per case. A.I. has become an increasingly powerful tool in the continuing coding wars between insurance companies on one side and hospitals and doctors on the other. Hammered by lawmakers at congressional committees, company executives and hospital officials have been pointing their fingers at each other for spiraling health costs. Dr. David Brailer, a health technology executive and former government health official, said A.I. would lower the costs of the weapons in these battles over billing. In a recent piece in Health Affairs, an academic journal, he predicted A.I. would be likely to increase overall health care spending. Dr. Brailer, who oversaw the George W. Bush administration's push to encourage the adoption of electronic health records, said hospitals had quickly seized on that new technology to bill more by being better able to document their care. "I don't think there is anything intrinsically different in A.I. that will escape the market forces," he said. Just as providers are using sophisticated A.I. tools to say their patients are sicker, insurance companies have been accused of using the tools to delay or deny care. The companies have come under intense criticism for their use of A.I. when requiring prior approval of treatments and medicines. A new pilot program in Medicare that relies on sophisticated technology to help determine whether certain kinds of care should be covered has come under attack by some lawmakers. While Medicare and the insurers insist they never deny care without oversight from a medical professional, the tools are adding to the overall friction between the parties. Patients are often caught in the middle, left with unpaid bills or denied care. "All the insurers are using A.I. to scan our charts to look for claims to deny. For the same reason, we're looking at the same charts today," said Dave Mazurkiewicz, the chief financial officer for McLaren Health Care, a small Michigan health system. McLaren buys A.I. technology from SmarterDx, which takes a cut of the additional revenues it generates. Mr. Mazurkiewicz said A.I. helped a doctor better document a patient's condition, like suggesting that the physician record the severity of a patient's kidney disease to justify a higher payment for care. If a doctor ordered a test, the tool might remind the physician that failing to document a potential diagnosis from that test would make it unbillable. McLaren has increased its revenue by $1 million a month through its adoption, adding to its small profits, according to Mr. Mazurkiewicz. While A.I. could ease tensions between insurers and hospitals and save money, it could also do the opposite, acknowledged Dr. Shiv Rao, a cardiologist who founded Abridge, which offers A.I. tools documenting patient care. "That's the danger," he said, "where it's bots fighting bots, agents fighting agents, a horrible dystopic future nobody wants to live in." The technology has already intensified the battles between insurers and hospitals, going several rounds over whether the insurer should pay a specific claim or authorize a treatment, said Caroline Pearson, the executive director of the Peterson Health Technology Institute, a nonprofit group that recently looked at the potential of A.I. to add to already high administrative costs. Both sides are willing to go these extra rounds "because it's cheap," she said. But as more hospitals and doctors use A.I., costs will continue to rise. Benefit consultants and insurers cite it as one of the factors that could lead to double-digit increases next year. A recent survey of employers suggested that costs could go up as much as 11 percent next year for employers unless they cut back on benefits. "We're still in the early period of that," said Eric Miller, an executive with Segal, which advises companies on their benefits. Mr. Chalker, representing Blue Cross, said the insurance plans were the main victims of this new wave of technology. "It's not a war," he said. "It is a completely one-sided blood bath." The Blue Cross plans are not using A.I. technology to administer claims, he said, although they are using it to guard against inappropriate billing. Some companies developing this technology are focused on maximizing the amount that providers can collect. "There is a different version of A.I. that is optimizing for revenue," said Amber Nigam, whose technology company, Basys.ai, advises private insurers and the Medicare program on how to review claims and spot potential abuses. "I am really, really concerned about what I'm seeing right now." By using sophisticated technology, the tools are becoming very skilled at packaging information, even combining treatments or conditions from different years, to justify an expensive procedure. While a human might do that from time to time, the newer technologies appear to do it seamlessly, Mr. Nigam said, making it much harder for the insurers to catch. A payment request might include physical therapy that was provided years ago, for example, to justify back surgery. These A.I. tools also allow for a much higher number of appeals when insurers deny approval for a procedure or refuse to pay a claim. Insurers are reporting an influx of appeals, with "a few fingerprints" that a large language model has been deployed, Mr. Nigam said. While providers may have given up too easily before the advent of A.I., they may be overly aggressive in appealing these decisions now. Some experts are less pessimistic. The technology is likely to save money by replacing the number of people needed to handle claims processing. "That frees up a huge share of cost," said David M. Cutler, a health economist from Harvard. Dr. Cutler and others say A.I. may also force a difficult conversation about how doctors and hospitals are paid. Insurers and hospitals could agree that the system needs to be much less complicated and focused more on paying for those services and medications that improve a patient's health. "It is going to put a ton of pressure on the reimbursement system to be better," Dr. Cutler said. At a recent event in New York, executives from Cigna, a large health insurer, and Emory Healthcare, an Atlanta health system, appeared on the same panel to discuss a potential truce in the coding wars. But while they celebrated their coming together, they also warned about an alternate path. "My nightmare is that we have bots on Emory Healthcare's side, bots on Cigna's side that keep talking to each other," said Dr. Joon S. Lee, the chief executive of Emory Healthcare. "A whole data center could be occupied just doing that."

PYMNTS
May 25th, 2025
Can Ai-Powered Smart Glasses Help Spot Medication Errors?

Every day, someone dies from getting the wrong medication or improper dosages of the right one. Now, researchers at the University of Washington (UW) are working on ways to solve this problem in part by using artificial intelligence (AI), NBC News reported Sunday (May 25). Dr. Kelly Michaelsen, an assistant professor of anesthesiology and pain medicine, told the network she had read studies at the prevalence of medication errors among anesthesiologists and began to wonder if AI could help spot errors

PR Newswire
May 13th, 2025
Smarterdx Named "Best Overall Healthcare Operations Solution" In 9Th Annual Medtech Breakthrough Awards Program

Prestigious international annual awards program recognizes standout digital health and medical technology products and companies.NEW YORK, May 8, 2025 /PRNewswire/ -- SmarterDx, the leader in clinical AI for revenue integrity and care quality, announced today that it has been selected as winner of the "Best Overall Healthcare Operations Solution" award in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market

JD Supra
Apr 30th, 2025
New Mountain Invests in SmarterDx AI

New Mountain Capital has made a strategic investment in SmarterDx, a New York-based company specializing in clinical AI for revenue integrity and care quality. New Mountain, also based in New York, is a growth-focused investment firm managing approximately $55 billion in assets. The terms of the investment were not disclosed.

FinSMEs
Apr 15th, 2025
SmarterDx Gains Investment from New Mountain

SmarterDx, a NYC-based clinical AI company, received an undisclosed investment from New Mountain Capital. The funds will support growth and product innovation. Founded in 2020, SmarterDx provides a platform to help hospitals analyze discharges and improve revenue integrity. Its solutions, SmarterPrebill™ and SmarterDenials™, assist in recovering revenue and improving care quality. Over 40 health systems with 180 hospital sites use its platform.

Recently Posted Jobs

Sign up to get curated job recommendations

SmarterDx is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs